Cargando…
Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer
BACKGROUND: Gallbladder cancer (GBC) is a mortal malignancy with limited therapeutic strategies. We aimed to develop novel immune scoring systems focusing on B7-H3, B7-H4, and HHLA2. We further investigated their potential clinical effects in predicting survival and immunotherapeutic efficacy for GB...
Autores principales: | Lv, Chao, Han, Shukun, Wu, Baokang, Liang, Zhiyun, Li, Yang, Zhang, Yizhou, Lang, Qi, Zhong, Chongli, Fu, Lei, Yu, Yang, Xu, Feng, Tian, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493478/ https://www.ncbi.nlm.nih.gov/pubmed/36159808 http://dx.doi.org/10.3389/fimmu.2022.984172 |
Ejemplares similares
-
HHLA2 promotes tumor progression by long non-coding RNA H19 in human gallbladder cancer
por: Zhang, Yizhou, et al.
Publicado: (2022) -
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022) -
Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways
por: Wu, Baokang, et al.
Publicado: (2021) -
Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization
por: Li, Yang, et al.
Publicado: (2023) -
B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling
por: Rieder, Sadiye Amcaoglu, et al.
Publicado: (2020)